Hydrochloric Acid

Hydrochloric Acid

SCHEMBL363004

CCCCC(N)(CCCC)CCCC.Cl

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
S1PR1 known ✓ P21453 2/20 0.36
S1PR4 known ✓ O95977 1/20 0.33
S1PR3 known ✓ Q99500 1/20 0.33
S1PR5 known ✓ Q9H228 1/20 0.33
FDPS P14324 3/20 0.44
DNM1 Q05193 6/20 0.38
TSHR P16473 2/20 0.38
LMNA P02545 1/20 0.38
SMPD1 P17405 2/20 0.36
THRB P10828 1/20 0.35
TNNC1 P63316 5/20 0.33
SGPL1 O95470 1/20 0.33
GPR183 P32249 1/20 0.33
CERS2 Q96G23 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL93609 0.97 FDPS (0.46) FDPSDNM1TSHRLMNAS1PR1
Hydrochloric Acid SCHEMBL9784204 0.94 FDPS (0.41) FDPSDNM1TSHRLMNAS1PR1
Hydrochloric Acid SCHEMBL1820523 0.94 FDPS (0.41) FDPSDNM1TSHRLMNAS1PR1
Hydrochloric Acid SCHEMBL5084825 0.94 FDPS (0.44) FDPSDNM1TSHRS1PR1SMPD1
Methyl Alcohol SCHEMBL22190212 0.94 FDPS (0.46) FDPSDNM1TSHRLMNAS1PR1
Hydrochloric Acid SCHEMBL11836901 0.94 FDPS (0.44) FDPSDNM1TSHRS1PR1SMPD1
Fluoride SCHEMBL4871826 0.93 FDPS (0.44) FDPSDNM1TSHRLMNAS1PR1
Bromide SCHEMBL309594 0.93 FDPS (0.44) FDPSDNM1TSHRLMNAS1PR1
Iodide SCHEMBL553007 0.93 FDPS (0.44) FDPSDNM1TSHRLMNAS1PR1
Water SCHEMBL661747 0.93 FDPS (0.44) FDPSDNM1TSHRLMNAS1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1032 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4735622-A1 PROTECTING FULLY FUNCTIONAL NUCLEOTIDES FROM DEGRADATION Illumina, Inc. (US) 2026-05-06 EP claimed
US-20260015560-A1 COMPOSITIONS FOR POST-CMP CLEANING OF MICROELECTRONIC DEVICES ENTEGRIS INC (US) 2026-01-15 US claimed
EP-4536612-A1 COMPOSITION COMPRISING A EUTECTIC MIXTURE COMPRISING AN ALKYLTHIOPHOSPHORIC TRIAMIDE UREASE INHIBITOR SPECIALTY OPERATIONS FRANCE (FR) 2025-04-16 EP claimed
CN-116178587-B Quaternary ammonium glycogen, composite antibacterial hydrogel and preparation method and application thereof 江南大学 2025-04-11 CN claimed
WO-2025003459-A1 PROTECTING FULLY FUNCTIONAL NUCLEOTIDES FROM DEGRADATION ILLUMINA, INC. (US) 2025-01-02 WO claimed
CN-119144153-A Flame-retardant antistatic polyamide and preparation method thereof 中化学科学技术研究有限公司 2024-12-17 CN claimed
CN-117039207-B Battery, iodine electrode material and preparation method of electrolyte 广东工业大学 2024-07-30 CN claimed
CN-118239909-A Ketone-containing bisfuranyl monomer compound, preparation method thereof, electronic packaging adhesive and application thereof 中国科学技术大学 2024-06-25 CN claimed
WO-2024081696-A2 COMPOSITIONS CONTAINING PHASE CHANGE MATERIALS, METHODS FOR FORMING OBJECTS USING THE SAME, AND METHOD FOR USING THE SAME PHASE CHANGE ENERGY SOLUTIONS, INC. (US) 2024-04-18 WO claimed
EP-3704086-B1 PROCESS FOR PREPARING 4-CHLOROBENZYL PROPARGYL ETHER BASF SE (DE) 2024-02-21 EP claimed
US-5420274-A Process for the preparation of 2,4-di(alkylamino)-6-alkylthio-s-triazines CIBA-GEIGY CORPORATION (US) 1995-05-30 US claimed
EP-0648755-A1 Improved process for the preparation of 2,4-Di(alkylamino)-6-alkylthio-s-triazines CIBA-GEIGY AG (CH) 1995-04-19 EP claimed
EP-0315906-B1 PROCESS FOR THE PREPARATION OF ORTHO-NITROPHENETOLE HOECHST AKTIENGESELLSCHAFT (DE) 1993-09-08 EP claimed
US-4954657-A Process for the preparation of o-nitrophenetole HOECHST AKTIENGESELLSCHAFT (DE) 1990-09-04 US claimed
EP-0171762-B1 PROCESS FOR PREPARING CARBOXYLATE ESTERS AIR PRODUCTS AND CHEMICALS, INC. (US) 1990-07-18 EP claimed
US-4847405-A AMINATION, PHASE TRANSFER AGENT AMERICAN CYANAMID COMPANY (US) 1989-07-11 US claimed
EP-0263205-A1 Processes for the preparation of compounds comprising substituted phenyl rings THE UPJOHN COMPANY (US) 1988-04-13 EP claimed
EP-0231257-A1 CHEMICAL COMPOUNDS COMRPISING SUBSTITUTED PHENYLRINGS THE UPJOHN COMPANY (US) 1987-08-12 EP claimed
WO-1987000519-A1 CHEMICAL COMPOUNDS COMRPISING SUBSTITUTED PHENYLRINGS THE UPJOHN COMPANY (US) 1987-01-29 WO claimed
EP-0171762-A2 Process for preparing carboxylate esters AIR PRODUCTS AND CHEMICALS, INC. (US) 1986-02-19 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260015560-A1 COMPOSITIONS FOR POST-CMP CLEANING OF MICROELECTRONIC DEVICES TET2, ASIC1, PIEZO1 S1PR1 702/4885S1PR4 1065/4885S1PR3 1349/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.